Inventor · disambiguated record
Greg Elson
Also filed as: ELSON GREG
36 granted patents·11 pending applications·493 citations·filing 2004–2023
97Inventor score
Top patents by PatentIndex Score
47 records- 0198US7728114B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Jun 1, 2010·260 cites·25 claims
- 0297US8609822B2Neutralizing antibodies and methods of use thereofELSON GREG·Filed 2012·Granted Dec 17, 2013·48 cites·4 claims
- 0393US8034344B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2009·Granted Oct 11, 2011·19 cites·6 claims
- 0493US7700098B2Anti-interferon gamma antibodies and methods of use thereofNOVIMMUNE SA·Filed 2006·Granted Apr 20, 2010·19 cites·9 claims
- 0593US7674884B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Mar 9, 2010·15 cites·3 claims
- 0692US9926382B2Methods for the generation of multispecific and multivalent antibodiesNOVIMMUNE SA·Filed 2013·Granted Mar 27, 2018·16 cites·12 claims
- 0791US7744884B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2007·Granted Jun 29, 2010·11 cites·12 claims
- 0890US10759862B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·3 cites·6 claims
- 0989US9682142B2Anti-interferon gamma antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jun 20, 2017·9 cites·10 claims
- 1089US7312320B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2004·Granted Dec 25, 2007·20 cites·14 claims
- 1188US9688755B2Fc receptor-binding polypeptides with modified effector functionsNOVIMMUNE SA·Filed 2013·Granted Jun 27, 2017·8 cites·7 claims
- 1288US8551478B2Anti-CD3 antibodies and methods of use thereofMACH BERNARD·Filed 2010·Granted Oct 8, 2013·14 cites·14 claims
- 1386US10047144B2Methods of purifying antibodiesNOVIMMUNE SA·Filed 2012·Granted Aug 14, 2018·8 cites·8 claims
- 1486US9834615B2Methods for the generation of multispecific and multivalent antibodiesFISCHER NICOLAS·Filed 2011·Granted Dec 5, 2017·5 cites·2 claims
- 1585US9850304B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Dec 26, 2017·5 cites·3 claims
- 1684US9828430B2Anti-IL-6/IL-6R antibodiesNOVIMMUNE SA·Filed 2016·Granted Nov 28, 2017·3 cites·4 claims
- 1783US9234034B2Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodiesNOVIMMUNE SA·Filed 2012·Granted Jan 12, 2016·4 cites·5 claims
- 1882US8546539B2Fc receptor-binding polypeptides with modified effector functionsELSON GREG·Filed 2008·Granted Oct 1, 2013·4 cites·7 claims
- 1981US10759858B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·1 cites·14 claims
- 2079US8337849B2Anti-IL6/IL-6R antibodiesFERLIN WALTER·Filed 2011·Granted Dec 25, 2012·4 cites·5 claims
- 2178US10689441B2Anti—TLR4 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2014·Granted Jun 23, 2020·4 cites·19 claims
- 2278US10597465B2Methods for the generation of multispecific and multivalent antibodiesNOVIMMUNE SA·Filed 2017·Granted Mar 24, 2020·1 cites·5 claims
- 2378US10023646B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Jul 17, 2018·1 cites·8 claims
- 2477US8105595B2Methods of using neutralizing anti-TLR4/MD2 antibodiesELSON GREG·Filed 2010·Granted Jan 31, 2012·2 cites·8 claims
- 2576US9540444B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jan 10, 2017·1 cites·6 claims
- 2675US10556960B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkersNOVIMMUNE SA·Filed 2017·Granted Feb 11, 2020·2 cites·18 claims
- 2774US11613582B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2020·Granted Mar 28, 2023·0 cites·2 claims
- 2874US10400044B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 2974US8617880B2Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereofELSON GREG·Filed 2012·Granted Dec 31, 2013·1 cites·6 claims
- 3074US8106018B2Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereofELSON GREG·Filed 2010·Granted Jan 31, 2012·1 cites·8 claims
- 3174US2022324994A1Anti-tlr4 antibodies and uses thereofNOVIMMUNE SA·Filed 2021·Application pending·0 cites
- 3272US9453076B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2013·Granted Sep 27, 2016·1 cites·13 claims
- 3371US2021009691A1Anti-cd3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2020·Application pending·0 cites
- 3470US10982004B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2019·Granted Apr 20, 2021·0 cites·11 claims
- 3569US10844132B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2018·Granted Nov 24, 2020·0 cites·8 claims
- 3668US9688769B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkersNOVIMMUNE SA·Filed 2014·Granted Jun 27, 2017·2 cites·18 claims
- 3765US2025197499A1Novel formats of anti-CD28/sPD-1 fusion constructsSTEALTH IO·Filed 2023·Application pending·0 cites
- 3864US9534049B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jan 3, 2017·0 cites·10 claims
- 3959US2017107296A1Neutralizing Antibodies and Methods of Use ThereofNOVIMMUNE SA·Filed 2017·Application pending·0 cites
- 4057US2017291943A1Anti-interferon gamma antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Application pending·0 cites
- 4154US2017298129A1Fc RECEPTOR-BINDING POLYPEPTIDES WITH MODIFIED EFFECTOR FUNCTIONSNOVLMMUNE SA·Filed 2017·Application pending·0 cites
- 4252US2007065437A1Anti-CD3 antibody formulationsELSON GREG·Filed 2006·Application pending·0 cites
- 4352US2010158922A1Anti-Interferon Gamma Antibodies and Methods of Use ThereofNOVIMMUNE SA·Filed 2010·Application pending·0 cites
- 4452US2010209437A1Anti-CD3 Antibody FromulationsELSON GREG·Filed 2006·Application pending·0 cites
- 4551US2019040117A1Methods of purifying antibodiesNOVIMMUNE SA·Filed 2018·Application pending·0 cites
- 4645US8029794B2Combining therapies targeting multiple toll-like receptorsNOVIMMUNE SA·Filed 2005·Granted Oct 4, 2011·0 cites·6 claims
- 4745US2010093087A1IL-17 Mediated Transfection MethodsNOVLMMUNE S A·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Greg Elson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →